Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in Myelofibrosis
NCT00667277Phase 2Terminated
- Start
- Mar 2008
- Primary completion
- Mar 2010
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in myelofibrosis (MF). Started Mar 2008; status: terminated.
02
Drugs
bevacizumab
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT00667277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00667277.